» Articles » PMID: 24101459

Phagocytosis Executes Delayed Neuronal Death After Focal Brain Ischemia

Overview
Specialty Science
Date 2013 Oct 9
PMID 24101459
Citations 197
Authors
Affiliations
Soon will be listed here.
Abstract

Delayed neuronal loss and brain atrophy after cerebral ischemia contribute to stroke and dementia pathology, but the mechanisms are poorly understood. Phagocytic removal of neurons is generally assumed to be beneficial and to occur only after neuronal death. However, we report herein that inhibition of phagocytosis can prevent delayed loss and death of functional neurons after transient brain ischemia. Two phagocytic proteins, Mer receptor tyrosine kinase (MerTK) and Milk fat globule EGF-like factor 8 (MFG-E8), were transiently up-regulated by macrophages/microglia after focal brain ischemia in vivo. Strikingly, deficiency in either protein completely prevented long-term functional motor deficits after cerebral ischemia and strongly reduced brain atrophy as a result of inhibiting phagocytosis of neurons. Correspondingly, in vitro glutamate-stressed neurons reversibly exposed the "eat-me" signal phosphatidylserine, leading to their phagocytosis by microglia; this neuronal loss was prevented in the absence of microglia and reduced if microglia were genetically deficient in MerTK or MFG-E8, both of which mediate phosphatidylserine-recognition. Thus, phagocytosis of viable neurons contributes to brain pathology and, surprisingly, blocking this process is strongly beneficial. Therefore, inhibition of specific phagocytic pathways may present therapeutic targets for preventing delayed neuronal loss after transient cerebral ischemia.

Citing Articles

Nasal anti-CD3 monoclonal antibody ameliorates traumatic brain injury, enhances microglial phagocytosis and reduces neuroinflammation via IL-10-dependent T-microglia crosstalk.

Izzy S, Yahya T, Albastaki O, Abou-El-Hassan H, Aronchik M, Cao T Nat Neurosci. 2025; 28(3):499-516.

PMID: 40016353 PMC: 11893472. DOI: 10.1038/s41593-025-01877-7.


The immunology of stroke and dementia.

Iadecola C, Anrather J Immunity. 2025; 58(1):18-39.

PMID: 39813992 PMC: 11736048. DOI: 10.1016/j.immuni.2024.12.008.


Molecular Targeting of Ischemic Stroke: The Promise of Naïve and Engineered Extracellular Vesicles.

Lee J, Geum D, Park D, Kim J Pharmaceutics. 2025; 16(12.

PMID: 39771472 PMC: 11678501. DOI: 10.3390/pharmaceutics16121492.


(Re)building the nervous system: A review of neuron-glia interactions from development to disease.

Demmings M, da Silva Chagas L, Traetta M, Rodrigues R, Acutain M, Barykin E J Neurochem. 2024; 169(1):e16258.

PMID: 39680483 PMC: 11649038. DOI: 10.1111/jnc.16258.


Efferocytosis: A new therapeutic target for stroke.

Gao L, Manaenko A, Zeng F, Li J, Liu L, Xie R Chin Med J (Engl). 2024; 137(23):2843-2850.

PMID: 39528491 PMC: 11649278. DOI: 10.1097/CM9.0000000000003363.


References
1.
Brown G, Neher J . Eaten alive! Cell death by primary phagocytosis: 'phagoptosis'. Trends Biochem Sci. 2012; 37(8):325-32. DOI: 10.1016/j.tibs.2012.05.002. View

2.
Eken C, Martin P, Sadallah S, Treves S, Schaller M, Schifferli J . Ectosomes released by polymorphonuclear neutrophils induce a MerTK-dependent anti-inflammatory pathway in macrophages. J Biol Chem. 2010; 285(51):39914-21. PMC: 3000973. DOI: 10.1074/jbc.M110.126748. View

3.
Reddien P, Cameron S, Horvitz H . Phagocytosis promotes programmed cell death in C. elegans. Nature. 2001; 412(6843):198-202. DOI: 10.1038/35084096. View

4.
Neher J, Neniskyte U, Brown G . Primary phagocytosis of neurons by inflamed microglia: potential roles in neurodegeneration. Front Pharmacol. 2012; 3:27. PMC: 3288722. DOI: 10.3389/fphar.2012.00027. View

5.
Gautier E, Shay T, Miller J, Greter M, Jakubzick C, Ivanov S . Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol. 2012; 13(11):1118-28. PMC: 3558276. DOI: 10.1038/ni.2419. View